Your account is not claimed yet. You can sign up with ORCID to claim your account.

Anna Wesołowska

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 3

Top Topics

Bipolar Disorder

Top Venues

Molecules (Basel, Switzerland)

Pharmaceuticals (Basel, Switzerland)

Uniwersytet Jagiellonski Collegium Medicum

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Uniwersytet Jagiellonski Collegium Medicum Jan 1o 2010

Poland

profesor :: Zakład Farmacji Klinicznej

Publications

Anna Partyka, Katarzyna Górecka, Joanna Gdula-Argasińska, Natalia Wilczyńska-Zawal, Magdalena Jastrzębska-Więsek, Anna Wesołowska
Selective 5-HT 6 Receptor Ligands (Agonist and Antagonist) Show Different Effects on Antipsychotic Drug-Induced Metabolic Dysfunctions in Rats. Pharmaceuticals (Basel, Switzerland) 16 (2) (2023)
Anna Czopek, Anna Partyka, Adam Bucki, Maciej Pawłowski, Marcin Kołaczkowski, Agata Siwek, Monika Głuch-Lutwin, Paulina Koczurkiewicz, Elżbieta Pękala, Anna Jaromin, Bozena Tyliszczak, Anna Wesołowska, Agnieszka Zagórska
Impact of N-Alkylamino Substituents on Serotonin Receptor (5-HTR) Affinity and Phosphodiesterase 10A (PDE10A) Inhibition of Isoindole-1,3-dione Derivatives. Molecules (Basel, Switzerland) 25 (17) (2020)
Annamaria Lubelska, Gniewomir Latacz, Magdalena Jastrzębska-Więsek, Magdalena Kotańska, Rafał Kurczab, Anna Partyka, Małgorzata Anna Marć, Daria Wilczyńska, Agata Doroz-Płonka, Dorota Łażewska, Anna Wesołowska, Katarzyna Kieć-Kononowicz, Jadwiga Handzlik
Are the Hydantoin-1,3,5-triazine 5-HT6R Ligands a Hope to a Find New Procognitive and Anti-Obesity Drug? Considerations Based on Primary In Vivo Assays and ADME-Tox Profile In Vitro. Molecules (Basel, Switzerland) 24 (24) (2019)